Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Raskob

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Chest|August 1, 1996
Pulmonary embolism among patients with a nearly normal ventilation/perfusion lung scanJ W Henry, P D Stein, A Gottschalk, et al.
Current Opinion in Hematology|September 1, 1999
Drug-induced thrombocytopeniaM A Rizvi, S R Shah, G E Raskob, et al.
The American Journal of Cardiology|November 1, 1996
Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study GroupG E Raskob, S S Durica, W L Owen, et al.
Archives of Internal Medicine|September 25, 1995
The low-probability lung scan. A need for change in nomenclatureR D Hull, G E Raskob, G F Pineo, et al.
Clinics in Chest Medicine|September 1, 1984
The diagnosis of clinically suspected venous thrombosisR D Hull, G E Raskob, J R LeClerc, et al.
Archives of Internal Medicine|November 1, 1989
A new noninvasive management strategy for patients with suspected pulmonary embolismR D Hull, G E Raskob, G Coates, et al.
Archives of Internal Medicine|October 6, 1998
Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital settingD W Bratzler, G E Raskob, C K Murray, et al.
Archives of Internal Medicine|November 15, 1997
The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrenceR D Hull, G E Raskob, R F Brant, et al.
Archives of Internal Medicine|April 8, 1998
Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosisR D Hull, G E Raskob, R F Brant, et al.
Blood|June 1, 1995
Effect of treatment with low-dose warfarin-aspirin on activated factor VIIG E Raskob, S S Durica, J H Morrissey, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Chest|August 1, 1996
Pulmonary embolism among patients with a nearly normal ventilation/perfusion lung scanJ W Henry, P D Stein, A Gottschalk, et al.
Current Opinion in Hematology|September 1, 1999
Drug-induced thrombocytopeniaM A Rizvi, S R Shah, G E Raskob, et al.
The American Journal of Cardiology|November 1, 1996
Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study GroupG E Raskob, S S Durica, W L Owen, et al.
Archives of Internal Medicine|September 25, 1995
The low-probability lung scan. A need for change in nomenclatureR D Hull, G E Raskob, G F Pineo, et al.
Clinics in Chest Medicine|September 1, 1984
The diagnosis of clinically suspected venous thrombosisR D Hull, G E Raskob, J R LeClerc, et al.
Archives of Internal Medicine|November 1, 1989
A new noninvasive management strategy for patients with suspected pulmonary embolismR D Hull, G E Raskob, G Coates, et al.
Archives of Internal Medicine|October 6, 1998
Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital settingD W Bratzler, G E Raskob, C K Murray, et al.
Archives of Internal Medicine|November 15, 1997
The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrenceR D Hull, G E Raskob, R F Brant, et al.
Archives of Internal Medicine|April 8, 1998
Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosisR D Hull, G E Raskob, R F Brant, et al.
Blood|June 1, 1995
Effect of treatment with low-dose warfarin-aspirin on activated factor VIIG E Raskob, S S Durica, J H Morrissey, et al.
Pageof 8